Soc. Generale Knock-Out AYJ/ DE000SW11FE9 /
2024-09-20 5:30:58 PM | Chg.+0.13 | Bid10:00:37 PM | Ask10:00:37 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.74EUR | +2.32% | - Bid Size: - |
- Ask Size: - |
VALNEVA SE EO... | 8.3143 EUR | 2078-12-31 | Put |
GlobeNewswire
09-03
Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidat...
GlobeNewswire
08-01
Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’...
GlobeNewswire
07-22
CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the Wo...
GlobeNewswire
07-17
Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion ...
GlobeNewswire
07-01
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ...
GlobeNewswire
06-26
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Direct...
GlobeNewswire
06-24
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
06-05
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Co...
GlobeNewswire
06-03
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire
05-13
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
GlobeNewswire
05-07
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
03-25
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
GlobeNewswire
03-21
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th Wo...
GlobeNewswire
03-20
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
GlobeNewswire
03-18
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and Orbi...
GlobeNewswire
03-04
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences